Log in

NASDAQ:PIRSPieris Pharmaceuticals SEC Filings & 10K Form

$3.40
+0.10 (+3.03 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.12
Now: $3.40
$3.42
50-Day Range
$2.34
MA: $2.74
$3.30
52-Week Range
$1.60
Now: $3.40
$6.04
Volume448,100 shs
Average Volume472,237 shs
Market Capitalization$177.89 million
P/E RatioN/A
Dividend YieldN/A
Beta1.43

SEC Filings

Pieris Pharmaceuticals (NASDAQ:PIRS) SEC Filings

DateFilerForm TypeView
05/21/2020
9:10 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
1:20 PM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
05/11/2020
6:15 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
4:19 PM
Pieris Pharmaceuticals (Filer)
Form DEFA14A
04/28/2020
4:16 PM
Pieris Pharmaceuticals (Filer)
Form DEF 14A
04/06/2020
3:11 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
6:04 PM
Aquilo Capital Management, LLC (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2020
4:22 PM
Pieris Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2020
6:39 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
3:03 PM
Bures Thomas (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:02 PM
Kaufmann Hitto (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
1:59 PM
Aquilo Capital Management, LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
7:45 AM
BlackRock Inc. (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G
01/28/2020
3:22 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:22 PM
Pieris Pharmaceuticals (Issuer)
Said Maya R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:22 PM
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:21 PM
Barbier Ann (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:20 PM
KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:52 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
8:24 AM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
01/21/2020
8:23 AM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
01/08/2020
7:02 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
11:15 PM
Pieris Pharmaceuticals (Filer)
Form EFFECT
12/04/2019
4:13 PM
Pieris Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/20/2019
7:09 AM
Pieris Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2019
3:45 PM
EcoR1 Capital, LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G
11/12/2019
7:39 AM
Pieris Pharmaceuticals (Filer)
Form 424B5
11/12/2019
6:32 AM
Pieris Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/12/2019
5:46 AM
Pieris Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
5:20 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
7:58 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
7:20 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
3:38 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2019
3:04 PM
Aquilo Capital Management, LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G
10/02/2019
6:58 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
7:08 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
8:56 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
8:22 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
6:51 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
5:00 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
4:57 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2019
4:49 PM
Kaufmann Hitto (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
4:47 PM
Kaufmann Hitto (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2019
4:45 PM
Bures Thomas (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2019
7:10 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
8:28 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:58 PM
Pieris Pharmaceuticals (Filer)
Form 424B5
08/09/2019
3:34 PM
Pieris Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2019
3:30 PM
Pieris Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
5:22 PM
Pieris Pharmaceuticals (Issuer)
Said Maya R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
5:21 PM
Pieris Pharmaceuticals (Issuer)
Said Maya R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2019
6:28 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
6:25 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
3:55 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
5:02 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
3:13 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
9:32 AM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
06/18/2019
3:07 PM
Pieris Pharmaceuticals (Filer)
Form DEFA14A
06/18/2019
3:05 PM
Pieris Pharmaceuticals (Filer)
Form DEF 14A
06/17/2019
6:53 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
7:38 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
1:34 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
8:46 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
3:50 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
8:09 AM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
05/10/2019
3:02 PM
Pieris Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2019
6:36 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
4:36 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
7:38 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
8:00 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
7:58 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
4:27 PM
Pieris Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2019
9:34 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
6:18 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
1:56 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G/A
02/04/2019
3:09 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2019
10:57 AM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:46 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:45 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:42 PM
Pieris Pharmaceuticals (Issuer)
Prelack Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:40 PM
KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:37 PM
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:35 PM
BIZZARI JEAN-PIERRE (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:35 PM
Barbier Ann (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:34 PM
GERAGHTY JAMES A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:13 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2018
5:32 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2018
7:26 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2018
7:54 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
11:32 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
6:27 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:34 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
4:11 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
4:21 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
4:19 PM
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
4:16 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/25/2018
7:31 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
8:02 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2018
3:43 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
09/19/2018
9:44 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.